SELECT LANGUAGE BELOW

European markets rise ahead of German debt reform vote; QinetiQ down 22% – CNBC

Qinetiq plummets after renewal trading

British defense company stocks Qinetiq It fell to the bottom of a Stoxx 600 on Monday morning, dropping 18.4% in London time by 8:46am.

It came after work Revised downwards The revenue outlook for the year ending March 31 says it expects organic revenue growth to be around 2% this year. The company had it Previously predicted Single digits of organic revenue growth annually.

Qinetiq cited “severe short-term transaction conditions” and geopolitical uncertainty as factors that consider its operation.

The company also said Monday that it expects an impairment fee of £140 million ($181 million) at the end of the year and an impairment fee of “one-time, exceptional, largely non-cash non-cash claims” totaling between £35 million and £40 million in total in light of US operational performance.

Chloe Taylor

AstraZeneca buys esobiotec for up to $1 billion

The office building of Biopharmaceutical Company Astrazeneca, located in Shanghai on May 23, 2024.

nuphoto | Getty Images

British drug maker AstraZeneca On Monday, he said he would buy biotech company Esobiotec for up to $1 billion to advance his cell therapy ambitions.

Unlike the current process that takes several weeks, the Esobiotec Engineered Nanobody Lentiviral platform helps patients attack potential “transformative cell therapy” in just minutes, Astrazeneca said.

Under this agreement, Astrazeneca will purchase all outstanding shares of Esobiotec on a cash and debt-free basis. This includes initial payment of $425 million upon transaction closure and conditions for up to $575 million for the development milestone.

“Esobiotec represents a major step forward in achieving our ambitions to accelerate and expand the impact of our recent investments and make the most of our cell therapy possibilities,” Susan Galbraith, Executive Vice President of Oncology and Haematology Research and Development at AstraZeneca, said in a statement.

Astrazeneca's shares rose 0.6% since the announcement.

– Karen Gilchrist

Trump reportedly says there is no exemption from steel or aluminum tariffs.

US President Donald Trump said he had no intention of applying for the exemption Steel and Aluminum Tariffsaccording to Reuters.

So, when mutual and sector duties will be imposed on April 2 alongside the car duties, the report added that it quotes Trump's comments to Air Force 1 reporters.

This follows the White House's 25% tariff on steel and aluminum imports that came into effect last Wednesday.

The measures were passed quickly from US trading partners. For example, the European Union said it would impose Tariffs of 26 billion euros ($28.33 billion) Correlation of US goods from April.

– Amara Balakrishna

CNBC Pro: Big Market Weeks Are First

Wall Street is desperate for investors to clarify the macroeconomic picture that can be put bottoms for stock prices.

The Federal Reserve is set to hold its latest policy meeting this week, but economic data will be scrutinized by laser-spurred investors for signs that consumers are pulling back. Elsewhere, Nvidia CEO Jensen Huang will focus on talking about the future of AI to take the stage at the GTC developer conference.

CNBC Pro subscribers can read the full story here.

– Salamine

European Market: Opening Calls are as follows

The European market is set to launch a new trading week in positive territory.

UK FTSE 100 The index is expected to be 21 points higher at 8,653 in Germany Dachshund France's 23,019 rises 90 points CAC 8,034 and 9 points for Italy ftse mib According to IG data, 38,819 is 182 points higher.

There will be no major revenue releases on Monday. However, in terms of data, Italy will publish the latest inflation printing.

– Holly Eliatt

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News